Eli Lilly | I Saldi



Sales Cambiamento Data
AbbVie USD 13.34B 1.76B 2025-03
Abbott USD 10.36B 610M 2025-03
ALKERMES USD 306.5M 123.5M 2025-03
Amgen USD 8.15B 936M 2025-03
AstraZeneca USD 13.59B 1.3B 2025-03
Baxter International USD 2.63B 123M 2025-03
Biogen USD 2.43B 24.7M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Drreddys Laboratories INR 83.59B 3.42B 2024-12
Eli Lilly USD 12.73B 802.8M 2025-03
Gilead Sciences USD 6.67B 899M 2025-03
GlaxoSmithKline GBP 7.52B 600M 2025-03
Glaxosmithkline GBP 8.12B 105M 2024-12
Indivior 266M 32M 2025-03
J&J USD 21.89B 630M 2025-03
Medtronic USD 8.29B 111M 2025-01
Merck USD 15.53B 94M 2025-03
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
Novartis USD 13.15B 330M 2024-12
Novartis USD 13.56B 386M 2024-12
Novo Nordisk 85.68B 14.37B 2024-12
Perrigo USD 1.14B 50.8M 2024-12
Pfizer USD 13.72B 4.04B 2025-03
Prestige Brands USD 290.32M 6.53M 2024-12
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 9.9B 660M 2025-03
Sanofi EUR 11.26B 3.5B 2024-12
United Therapeutics USD 794.4M 58.5M 2025-03
Zoetis USD 2.32B 71M 2024-12



Eli Lilly I Saldi - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.